Publications 2000 [References 52–77]

52. Hull BP, McIntyre PB. Immunisation coverage reporting through the Australian Childhood Immunisation Register – an evaluation of the third-dose assumption. Australian and New Zealand Journal of Public Health 2000;24:17-21. [full text]

53. McIntyre PB, Gidding HF, Gilbert GL. Measles in an era of measles control [editorial]. Medical Journal of Australia 2000;172:103-4. [no abstract available]

54. D'Souza RM, Campbell-Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F, O'Brien E. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign. Communicable Diseases Intelligence 2000;24:27-33. [full text]

55. Forrest JM, Mego S, Burgess MA. Congenital and neonatal varicella in Australia. Journal of Paediatrics and Child Health 2000;36:108-13. [abstract]

56. McIntyre P. Back pain in a 4-year-old boy. Journal of Paediatrics and Child Health 2000;36:275-6. [no abstract available]

57. Forrest JM, Burgess MA, McIntyre PB. Factors influencing vaccination uptake. Workshop report: Current Australian research on the behavioural, social and demographic factors influencing immunisation, Royal Alexandra Hospital for Children, Sydney, March 1998. Communicable Diseases Intelligence 2000;24:51-3. [full text]

58. Forrest JM, McIntyre PB, Burgess MA. Pneumococcal disease in Australia. Summary of the Pneumococcal Disease in Australia: Epidemiology, Surveillance and Immunisation Workshop, convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Royal Alexandra Hospital for Children, Sydney, 26–27 March 1999. Communicable Diseases Intelligence 2000;24:89-92. [full text]

59. McIntyre P, Menzies R, Krause V, Selvey L, Hall R, Misrachi A, Andrews R, Giele C, Gill J. Surveillance of pneumococcal disease in Australian states and territories. Communicable Diseases Intelligence 2000;24:93-5. [full text]

60. Lister S, McIntyre P, Menzies R. The epidemiology of respiratory syncytial virus infections in NSW children, 1992–1997. New South Wales Public Health Bulletin 2000;11:119-23. [full text]

61. Guthridge S, McIntyre P, Isaacs D, Hanlon M, Patel M. Differing serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in Australian Aboriginal and Caucasian infants – implications for disease epidemiology. Vaccine 2000;18:2584-91. [abstract]

62. Hanlon MG, Nambiar R, Kakakios AM, McIntyre P, Land MV, Devine PL. Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole-cell pertussis ELISA. Immunology and Cell Biology 2000;78:254-8. [full text]

63. Gold M, Goodwin H, Botham S, Burgess M, Nash M, Kempe A. Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Archives of Disease in Childhood 2000;83:128-31. [full text]

64. Hull BP, McIntyre PB. A re-evaluation of immunisation coverage estimates from the Australian Childhood Immunisation Register. Communicable Diseases Intelligence 2000;24:161-4. [full text]

65. Gidding HF, Burgess MA, Gilbert GL. Diphtheria in Australia, recent trends and future prevention strategies. Communicable Diseases Intelligence 2000;24:165-7. [full text]

66. Thomas PF, McIntyre PB, Jalaludin BB. Survey of pertussis morbidity in adults in western Sydney. Medical Journal of Australia 2000;173:74-6. [abstract]

67. McIntyre PB, Gilmour RE, Gilbert GL, Kakakios AM, Mellis CM. Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997–1999. Medical Journal of Australia 2000;173(Suppl):S22-S6. [abstract]

68. McIntyre PB, Nolan TM. Conjugate pneumococcal vaccines for non-Indigenous children in Australia. Medical Journal of Australia 2000;173(Suppl):S54-S7. [abstract]

69. Burgess MA, Forrest JM. Congenital rubella. In: Elliott E, Williams K, Ridley G, Morris A, Redmond D, Williams G (editors). Australian Paediatric Surveillance Unit Seventh Annual Report 1999. Sydney: APSU; 2000. p. 23-4. [no abstract available]

70. McIntyre PB, Burgess MA, Lester R. Immunisation in the age of the human genome. Australian and New Zealand Journal of Public Health 2000;24:351-2. [full text]

71. Gidding HF, Amin J, McIntyre PB. Notifications of vaccine preventable diseases in Australia. Quarterly report (January–March 2000). Communicable Diseases Intelligence 2000;24:239-41. [full text]

72. McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, Tucker A, Turnbull F, Burgess M. Vaccine preventable diseases and vaccination coverage in Australia, 1993–1998. Communicable Diseases Intelligence 2000;24(Suppl):v-S83. [full text]

73. McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, Tucker A, Turnbull F, Burgess M. Vaccine preventable diseases and vaccination coverage in Australia, 1993–1998 [report summary]. Communicable Diseases Intelligence 2000;24:276-7. [full text]

74. Causer J, Mira M, Karr M, Hueston L, Burgess M, Alperstein G, Fett M, Cunningham A. Serological survey of measles and rubella immunity in Sydney preschool children. Journal of Paediatrics and Child Health 2000;36:418-21. [abstract]

75. Turnbull FM, Heath TC, Jalaludin BB, Burgess MA, Ramalho AC. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. Vaccine 2000;19:628-36. [abstract]

76. O'Grady KA, Merianos A, Patel M, Gilbert L. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate. Tropical Medicine and International Health 2000;5:732-6. [full text]

77. McIntyre P, Hull B. Immunisation coverage estimates [letter]. Communicable Diseases Intelligence 2000;24:268. [full text]